# Jillian Rosenthal

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jillian-rosenthal/

## Facts

| Field | Value |
| --- | --- |
| Citations | 192 |
| Field | Vasculitis and related conditions |
| h-index | 6 |
| i10-index | 5 |
| Last Known Institution | Massachusetts General Hospital |
| OpenAlex ID | https://openalex.org/A5111090500 |
| Works | 12 |

## Researcher papers

- [Incidence, Clinical Features, and Outcomes of Late‐Onset Neutropenia From Rituximab for Autoimmune Disease](https://scholariq.org/papers/incidence-clinical-features-and-outcomes-of-late-onset-neutropenia-from/)
- [Continuous B-cell depletion in frequently relapsing, steroid-dependent and steroid-resistant nephrotic syndrome](https://scholariq.org/papers/continuous-b-cell-depletion-in-frequently-relapsing-steroid-dependent-and/)
- [Reduction of regrowing hair shaft size and pigmentation after ruby and diode laser treatment](https://scholariq.org/papers/reduction-of-regrowing-hair-shaft-size-and-pigmentation-after-ruby-and-diode/)
- [Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial](https://scholariq.org/papers/maintenance-of-remission-of-anca-vasculitis-by-rituximab-based-on-b-cell/)
- [Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab](https://scholariq.org/papers/treatment-of-aggressive-antineutrophil-cytoplasmic-antibody-associated/)
- [Inflammatory vaginitis in women on long-term rituximab treatment for autoimmune disorders](https://scholariq.org/papers/inflammatory-vaginitis-in-women-on-long-term-rituximab-treatment-for-autoimmune/)
- [364. LATE-ONSET NEUTROPENIA IN PATIENTS UNDERGOING RITUXIMAB-INDUCED CONTINUOUS B CELL DEPLETION FOR AUTOIMMUNE DISEASE: DATA FROM A 738 PATIENT COHORT AND APPROACH TO MANAGEMENT](https://scholariq.org/papers/364-late-onset-neutropenia-in-patients-undergoing-rituximab-induced-continuous-b/)
- [314. MATERNOFETAL OUTCOMES IN PREGNANCIES WITH GESTATIONAL RITUXIMAB EXPOSURE](https://scholariq.org/papers/314-maternofetal-outcomes-in-pregnancies-with-gestational-rituximab-exposure/)
- [Time to CD20 B-Cell Return After Rituximab in Patients with Antineutrophil Cytoplasmic Antibody Vasculitis](https://scholariq.org/papers/time-to-cd20-b-cell-return-after-rituximab-in-patients-with-antineutrophil/)
- [Effect of COVID-19 Infection in Three Patients Treated with Rituximab](https://scholariq.org/papers/effect-of-covid-19-infection-in-three-patients-treated-with-rituximab/)

## Researcher topics

- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)

## Researcher university

- [Massachusetts General Hospital](https://scholariq.org/institutions/massachusetts-general-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.